Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 13, 2026
During the third quarter of 2026, the Oakmark Global Select Fund (Investor Class) delivered strong absolute and relative performance, returning +5.14% net of fees and outperforming its benchmark, the MSCI World Index, which gained +1.88%. Year-to-date, the fund has returned +0.23% net of fees. At the sector level, capital allocation in health care and information technology served as the primary performance contributors, offsetting negative drag from consumer discretionary and industrials holdings. Geographically, the fund maintained significant core exposures with 61.1% allocated to the United States, 22.2% to Europe ex-U.K., 9.5% to the United Kingdom, and 3.0% to emerging markets, with U.S., German, and Chinese positions generating the strongest performance attribution. Macroeconomic conditions continued to reflect pronounced market narrowness, as a small cohort of mega-cap technology and growth companies drove broader U.S. index returns. Simultaneously, international markets faced persistent friction stemming from foreign currency volatility, European economic stagnation, and ongoing macroeconomic softness in China. Oakmark’s investment framework views these macro dislocations and narrow market participation not as structural impediments, but as fertile ground for fundamental value investing. The managers emphasize that broad sentiment skepticism has depressed the market prices of durable, cash-generative global franchises well below their underlying intrinsic business values. Portfolio activity during the quarter reflected proactive capital reallocation into newly identified value opportunities. Oakmark initiated new equity positions in building materials producer Amrize (2.5% weighting), global luxury powerhouse LVMH (1.8% weighting), and commercial insurance broker Willis Towers Watson (2.8% weighting). Top quarterly contributor IQVIA Holdings (6.9% weighting) surged following accelerated bookings growth and AI tool adoption, while Danish freight forwarder DSV (3.6% weighting) detracted due to transitory execution hurdles in European road logistics. To fund new purchases and optimize portfolio concentration, the managers executed complete sales of their holdings in BMW and ConocoPhillips.
Invest with a patient, long-term horizon in well-managed, high-quality global companies trading at substantial discounts to intrinsic value to capture superior risk-adjusted capital compounding.
Patient investors are well-positioned to benefit as the gap between market price and intrinsic business value narrows over time across attractively valued global franchises.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Oakmark Global Select Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.